These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 24875598

  • 1. Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors.
    Jo DH, An H, Chang DJ, Baek YY, Cho CS, Jun HO, Park SJ, Kim JH, Lee HY, Kim KW, Lee J, Park HJ, Kim YM, Suh YG, Kim JH.
    J Mol Med (Berl); 2014 Oct; 92(10):1083-92. PubMed ID: 24875598
    [Abstract] [Full Text] [Related]

  • 2. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
    Lin M, Chen Y, Jin J, Hu Y, Zhou KK, Zhu M, Le YZ, Ge J, Johnson RS, Ma JX.
    Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.
    Zhao K, Jiang Y, Zhang J, Shi J, Zheng P, Yang C, Chen Y.
    Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways.
    Sun K, Chen Y, Zheng S, Wan W, Hu K.
    Phytomedicine; 2024 Jul; 129():155596. PubMed ID: 38626646
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant thrombomodulin domain 1 rescues pathological angiogenesis by inhibition of HIF-1α-VEGF pathway.
    Huang YH, Kuo CH, Peng IC, Chang YS, Tseng SH, Conway EM, Wu HL.
    Cell Mol Life Sci; 2021 Dec; 78(23):7681-7692. PubMed ID: 34705054
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy.
    Li HY, Yuan Y, Fu YH, Wang Y, Gao XY.
    Pharmacol Res; 2020 Sep; 159():104924. PubMed ID: 32464323
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N, Xu H, Yu N, Wu Y, Yu L.
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.